PriceTargets.com logo

EverQuote - EVER Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $28.50
  • Forecasted Upside: 51.19%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$18.85 As of 11/20/2024 01:00 AM ET
▲ +0.06 (0.32%)

This chart shows the closing price for EVER by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New EverQuote Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EVER and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EVER

Analyst Price Target is $28.50
▲ +51.19% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for EverQuote in the last 3 months. The average price target is $28.50, with a high forecast of $38.00 and a low forecast of $13.00. The average price target represents a 51.19% upside from the last price of $18.85.

This chart shows the closing price for EVER for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 6 polled investment analysts is to buy stock in EverQuote. This rating has held steady since March 2024, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
5/30/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/24/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/22/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/21/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/5/2024B. RileyLower TargetBuy ➝ Buy$36.50 ➝ $29.00
11/5/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$34.00 ➝ $28.00
8/6/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$29.00 ➝ $34.00
8/6/2024Craig HallumBoost TargetBuy ➝ Buy$30.00 ➝ $33.00
8/6/2024Needham & Company LLCBoost TargetBuy ➝ Buy$30.00 ➝ $38.00
5/7/2024B. RileyBoost TargetBuy ➝ Buy$24.00 ➝ $29.50
5/7/2024Craig HallumBoost TargetBuy ➝ Buy$26.00 ➝ $30.00
5/7/2024Canaccord Genuity GroupBoost TargetBuy ➝ Buy$25.00 ➝ $30.00
5/7/2024Needham & Company LLCBoost TargetBuy ➝ Buy$25.00 ➝ $30.00
4/19/2024B. RileyInitiated CoverageBuy$24.00
2/27/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$13.00 ➝ $25.00
2/27/2024B. RileyBoost TargetBuy ➝ Buy$18.00 ➝ $25.00
2/27/2024Needham & Company LLCBoost TargetBuy ➝ Buy$15.00 ➝ $25.00
2/1/2024B. RileyBoost TargetBuy ➝ Buy$14.00 ➝ $18.00
1/26/2024Needham & Company LLCBoost TargetBuy ➝ Buy$10.00 ➝ $15.00
12/12/2023Raymond JamesUpgradeMarket Perform ➝ Outperform$13.00
12/5/2023Craig HallumInitiated CoverageBuy$16.00
11/30/2023B. RileyUpgradeNeutral ➝ Buy$8.00 ➝ $14.00
11/7/2023Needham & Company LLCBoost TargetBuy ➝ Buy$8.00 ➝ $10.00
10/10/2023B. RileyBoost Target$6.00 ➝ $7.00
8/8/2023B. RileyLower Target$8.00 ➝ $6.00
8/8/2023Needham & Company LLCLower TargetBuy ➝ Buy$10.00 ➝ $8.00
5/9/2023Needham & Company LLCLower Target$21.00 ➝ $10.00
4/17/2023OppenheimerDowngradeOutperform ➝ Market Perform
2/28/2023Needham & Company LLCReiterated RatingBuy$21.00
2/28/2023B. RileyBoost TargetNeutral$9.00 ➝ $12.00
2/28/2023JPMorgan Chase & Co.Boost TargetOverweight$15.00 ➝ $18.00
1/19/2023OppenheimerBoost TargetOutperform$8.00 ➝ $22.00
1/18/2023Needham & Company LLCBoost TargetBuy$8.00 ➝ $21.00
12/20/2022JPMorgan Chase & Co.UpgradeUnderweight ➝ Overweight$8.00 ➝ $15.00
11/2/2022Needham & Company LLCLower TargetBuy$15.00 ➝ $8.00
9/22/2022B. RileyReiterated RatingNeutral$9.00
8/2/2022Needham & Company LLCLower TargetBuy$16.00 ➝ $15.00
5/3/2022Needham & Company LLCLower Target$19.00 ➝ $16.00
5/3/2022Canaccord Genuity GroupLower TargetBuy ➝ Buy$25.00 ➝ $22.00
5/3/2022OppenheimerLower Target$20.00 ➝ $15.00
5/3/2022William BlairDowngradeOutperform ➝ Market Perform
5/3/2022Raymond JamesDowngradeOutperform ➝ Market Perform
4/18/2022B. RileyInitiated CoverageBuy$20.00
2/17/2022Needham & Company LLCBoost TargetBuy$17.00 ➝ $19.00
2/17/2022Raymond JamesLower TargetOutperform$26.00 ➝ $19.00
12/15/2021JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$17.00 ➝ $13.00
11/2/2021Needham & Company LLCLower TargetBuy$19.00 ➝ $17.00
11/2/2021Raymond JamesLower TargetOutperform$41.00 ➝ $26.00
11/2/2021OppenheimerLower TargetOutperform$45.00 ➝ $20.00
11/2/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$41.00 ➝ $17.00
10/19/2021Needham & Company LLCLower TargetPositive ➝ Buy$45.00 ➝ $19.00
8/3/2021Raymond JamesLower TargetOutperform$50.00 ➝ $41.00
8/3/2021Needham & Company LLCLower TargetBuy$65.00 ➝ $45.00
8/3/2021OppenheimerLower TargetOutperform$55.00 ➝ $45.00
8/3/2021JMP SecuritiesLower TargetMarket Outperform$64.00 ➝ $45.00
7/26/2021JPMorgan Chase & Co.Initiated CoverageBuy$41.00
5/24/2021OppenheimerReiterated RatingBuy$55.00
5/4/2021OppenheimerBoost TargetOutperform$55.00 ➝ $70.00
5/4/2021Raymond JamesLower TargetOutperform$58.00 ➝ $50.00
2/23/2021Needham & Company LLCReiterated RatingBuy$65.00
2/23/2021Raymond JamesBoost TargetOutperform$51.00 ➝ $58.00
2/23/2021OppenheimerReiterated RatingBuy$55.00 ➝ $70.00
12/16/2020JPMorgan Chase & Co.Lower TargetOverweight$54.00 ➝ $48.00
11/3/2020JPMorgan Chase & Co.Lower TargetOverweight$60.00 ➝ $54.00
11/3/2020OppenheimerLower TargetOutperform$65.00 ➝ $55.00
11/3/2020Raymond JamesLower TargetOutperform$63.00 ➝ $51.00
11/3/2020OppenheimerInitiated CoverageBuy$65.00 ➝ $55.00
8/12/2020OppenheimerReiterated RatingBuy$65.00
8/5/2020Needham & Company LLCBoost TargetBuy$55.00 ➝ $65.00
8/5/2020Raymond JamesBoost TargetOutperform$49.00 ➝ $63.00
7/14/2020Bank of AmericaDowngradeNeutral ➝ Underperform$48.00
6/2/2020OppenheimerBoost TargetOutperform$50.00 ➝ $65.00
5/5/2020JMP SecuritiesBoost TargetMarket Outperform$50.00 ➝ $53.00
5/5/2020Needham & Company LLCBoost TargetPositive ➝ Buy$45.00 ➝ $55.00
5/5/2020OppenheimerReiterated RatingBuy$50.00
3/27/2020StephensReiterated RatingBuy
3/26/2020Needham & Company LLCLower TargetBuy$50.00 ➝ $45.00
3/18/2020JPMorgan Chase & Co.Lower TargetOverweight$51.00 ➝ $39.00
2/27/2020JMP SecuritiesBoost TargetOutperform$35.00 ➝ $50.00
2/26/2020Bank of AmericaDowngradeBuy ➝ Neutral$45.00
2/25/2020OppenheimerBoost Target$41.00 ➝ $50.00
2/25/2020JPMorgan Chase & Co.Boost TargetPositive ➝ Overweight$35.00 ➝ $51.00
2/25/2020Needham & Company LLCBoost TargetBuy$35.00 ➝ $50.00
2/25/2020Raymond JamesReiterated RatingOutperform$30.00 ➝ $49.00
12/2/2019OppenheimerReiterated RatingBuy$33.00 ➝ $41.00
(Data available from 11/21/2019 forward)

News Sentiment Rating

0.66 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 12 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024
  • 16 very positive mentions
  • 16 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
5/24/2024
  • 9 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/23/2024
  • 11 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/23/2024
  • 18 very positive mentions
  • 24 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/22/2024
  • 16 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/21/2024
  • 22 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/21/2024
  • 15 very positive mentions
  • 19 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
11/20/2024

Current Sentiment

  • 15 very positive mentions
  • 19 positive mentions
  • 2 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

EverQuote logo
EverQuote, Inc. operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc., and changed its name to EverQuote, Inc. in November 2014. EverQuote, Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.
Read More

Today's Range

Now: $18.85
Low: $18.80
High: $19.64

50 Day Range

MA: $19.77
Low: $17.22
High: $22.60

52 Week Range

Now: $18.85
Low: $8.18
High: $28.09

Volume

353,902 shs

Average Volume

474,118 shs

Market Capitalization

$666.37 million

P/E Ratio

55.44

Dividend Yield

N/A

Beta

1.06

Frequently Asked Questions

What sell-side analysts currently cover shares of EverQuote?

The following Wall Street sell-side analysts have issued research reports on EverQuote in the last year: B. Riley, Canaccord Genuity Group Inc., Craig Hallum, JPMorgan Chase & Co., Needham & Company LLC, and Raymond James.
View the latest analyst ratings for EVER.

What is the current price target for EverQuote?

0 Wall Street analysts have set twelve-month price targets for EverQuote in the last year. Their average twelve-month price target is $28.50, suggesting a possible upside of 51.2%. Needham & Company LLC has the highest price target set, predicting EVER will reach $38.00 in the next twelve months. Raymond James has the lowest price target set, forecasting a price of $13.00 for EverQuote in the next year.
View the latest price targets for EVER.

What is the current consensus analyst rating for EverQuote?

EverQuote currently has 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe EVER will outperform the market and that investors should add to their positions of EverQuote.
View the latest ratings for EVER.

What other companies compete with EverQuote?

Other companies that are similar to EverQuote include Health Catalyst, HealthStream, TrueCar, Eventbrite and Model N. Learn More about companies similar to EverQuote.

How do I contact EverQuote's investor relations team?

EverQuote's physical mailing address is 210 BROADWAY, CAMBRIDGE MA, 02139. The company's listed phone number is (855) 522-3444 and its investor relations email address is [email protected]. The official website for EverQuote is www.everquote.com. Learn More about contacing EverQuote investor relations.